224 related articles for article (PubMed ID: 24199985)
1. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
[TBL] [Abstract][Full Text] [Related]
2. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
3. Influence of Primary Ligands (ODA, TDA) on Physicochemical and Biological Properties of Oxidovanadium (IV) Complexes with Bipy and Phen as Auxiliary Ligands.
Pranczk J; Tesmar A; Wyrzykowski D; Inkielewicz-Stępniak I; Jacewicz D; Chmurzyński L
Biol Trace Elem Res; 2016 Nov; 174(1):251-258. PubMed ID: 27048276
[TBL] [Abstract][Full Text] [Related]
4. Cyto- and genotoxicity of a vanadyl(IV) complex with oxodiacetate in human colon adenocarcinoma (Caco-2) cells: potential use in cancer therapy.
Di Virgilio AL; Rivadeneira J; Muglia CI; Reigosa MA; Butenko N; Cavaco I; Etcheverry SB
Biometals; 2011 Dec; 24(6):1153-68. PubMed ID: 21755303
[TBL] [Abstract][Full Text] [Related]
5. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties of ternary oxovanadium(IV) complexes with oxydiacetate and 1,10-phenanthroline or 2,2'-bipyridine. Cytoprotective activity in hippocampal neuronal HT22 cells.
Wyrzykowski D; Inkielewicz-Stępniak I; Pranczk J; Żamojć K; Zięba P; Tesmar A; Jacewicz D; Ossowski T; Chmurzyński L
Biometals; 2015 Apr; 28(2):307-20. PubMed ID: 25656562
[TBL] [Abstract][Full Text] [Related]
7. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
8. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
9. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
[TBL] [Abstract][Full Text] [Related]
10. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
11. Copper complex with sulfamethazine and 2,2'-bipyridine supported on mesoporous silica microspheres improves its antitumor action toward human osteosarcoma cells: cyto- and genotoxic effects.
Cadavid-Vargas JF; Arnal PM; Mojica Sepúlveda RD; Rizzo A; Soria DB; Di Virgilio AL
Biometals; 2019 Feb; 32(1):21-32. PubMed ID: 30334122
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
[TBL] [Abstract][Full Text] [Related]
13. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization; DNA binding and antitumor activity of ruthenium(II) polypyridyl complexes.
Srishailam A; Gabra NM; Kumar YP; Reddy KL; Devi CS; Anil Kumar D; Singh SS; Satyanarayana S
J Photochem Photobiol B; 2014 Dec; 141():47-58. PubMed ID: 25318017
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of a vanadyl(IV) complex with a multidentate oxygen donor in osteoblast cell lines in culture.
Rivadeneira J; Di Virgilio AL; Barrio DA; Muglia CI; Bruzzone L; Etcheverry SB
Med Chem; 2010 Jan; 6(1):9-23. PubMed ID: 20402656
[TBL] [Abstract][Full Text] [Related]
16. Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity.
Jaividhya P; Dhivya R; Akbarsha MA; Palaniandavar M
J Inorg Biochem; 2012 Sep; 114():94-105. PubMed ID: 22841366
[TBL] [Abstract][Full Text] [Related]
17. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
[TBL] [Abstract][Full Text] [Related]
18. Ru(ii)-(PTA) and -mPTA complexes with N
Wołoszyn A; Pettinari C; Pettinari R; Badillo Patzmay GV; Kwiecień A; Lupidi G; Nabissi M; Santoni G; Smoleński P
Dalton Trans; 2017 Aug; 46(30):10073-10081. PubMed ID: 28731114
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
20. DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium (IV) complexes with substituted isoniazid.
Liao X; Lu J; Ying P; Zhao P; Bai Y; Li W; Liu M
J Biol Inorg Chem; 2013 Dec; 18(8):975-84. PubMed ID: 24077688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
